We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$40.3B
AUM Growth
-$1.82B
Cap. Flow
+$332M
Cap. Flow %
0.83%
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$231M
2
GILD icon
Gilead Sciences
GILD
+$113M
3
PCG icon
PG&E
PCG
+$102M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$80.2M
5
ALL icon
Allstate
ALL
+$64.4M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$472M
2
ABBV icon
AbbVie
ABBV
+$121M
3
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$69.5M
4
CRM icon
Salesforce
CRM
+$64.3M
5
HD icon
Home Depot
HD
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 19.03%
3 Financials 13.02%
4 Consumer Discretionary 9.39%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACK icon
2301
Ranpak Holdings
PACK
$572M
$28K ﹤0.01%
8,180
+3,680
+82% +$20.2K
CYXT
2302
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$28K ﹤0.01%
+6,780
New +$59.7K
EVGO icon
2303
EVgo
EVGO
$220M
$27K ﹤0.01%
+3,470
New +$30.2K
SWIM icon
2304
Latham Group
SWIM
$661M
$27K ﹤0.01%
7,530
+1,120
+17% +$6.39K
UA icon
2305
Under Armour Class C
UA
$2.95B
$26K ﹤0.01%
+4,380
New +$34.3K
AMPS
2306
DELISTED
Altus Power
AMPS
$26K ﹤0.01%
+2,350
New +$22.4K
DNA.WS
2307
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$12K ﹤0.01%
16,100
XLB icon
2308
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$6K ﹤0.01%
162
-46,058
-100% -$1.73M
XLI icon
2309
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
$3K ﹤0.01%
34
-57,496
-100% -$5.29M
ALLK
2310
DELISTED
Allakos
ALLK
-17,080
Closed -$53K
ALXO icon
2311
ALX Oncology
ALXO
$272M
-1,350
Closed -$11K
BLDP
2312
Ballard Power Systems
BLDP
$865M
-10,700
Closed -$69K
BLUE
2313
DELISTED
bluebird bio
BLUE
-2,543
Closed -$211K
BROS icon
2314
Dutch Bros
BROS
$9.01B
-910
Closed -$29K
CRSP icon
2315
CRISPR Therapeutics
CRSP
$4.6B
-37,169
Closed -$2.26M
CUE icon
2316
Cue Biopharma
CUE
$137M
-599
Closed -$45K
CVM icon
2317
CEL-SCI Corp
CVM
$20.6M
-900
Closed -$121K
CYH icon
2318
Community Health Systems
CYH
$383M
-40,190
Closed -$151K
DADA
2319
DELISTED
Dada Nexus
DADA
-4,100
Closed -$33K
EHTH icon
2320
eHealth
EHTH
$43.2M
-14,246
Closed -$133K
EPIX
2321
DELISTED
ESSA Pharma
EPIX
-26,282
Closed -$83K
FUBO icon
2322
FuboTV Inc
FUBO
$256M
-53,498
Closed -$1.59M
FVRR icon
2323
Fiverr
FVRR
$398M
-2,050
Closed -$70K
TDAY
2324
USA Today Co
TDAY
$1.22B
-89,070
Closed -$258K
GLUE icon
2325
Monte Rosa Therapeutics
GLUE
$1.91B
-240
Closed -$2K

Similar funds

Ensign Peak Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
  • Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
  • Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
  • Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
  • Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
  • Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.